Aiberry AI Mental Health Screening Platform

NCT04994899 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 800

Last updated 2023-06-09

No results posted yet for this study

Summary

Aiberry is creating a multi-modal artificial intelligence (AI) platform that analyzes facial, audio and text features to screen for mental illness. This multicenter study will be used to collect data to validate the platform's ability to detect depression and anxiety in a diverse patient population.

Conditions

Sponsors & Collaborators

  • Aiberry, Inc

    lead INDUSTRY

Eligibility

Min Age
13 Years
Max Age
79 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-09-22
Primary Completion
2023-04-06
Completion
2023-04-06

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04994899 on ClinicalTrials.gov